75 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
prices, lower reimbursement rates and smaller populations for whom payers will reimburse; changes under the 340B Drug Pricing Program; the company’s
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
populations for whom payers will reimburse; changes under the 340B Drug Pricing Program; our ability to obtain and maintain regulatory approval
424B2
yy2bcouy9w3i3d5kyk
13 Feb 24
Prospectus for primary offering
8:00am
8-K
EX-99.1
6ub u5pth9
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
424B5
awtlqyyf54q2oly4pb9x
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
g6sg6
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.1
5zlrbypci7yqjef61whe
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
06t5rbx830d yxrx
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.1
gpk0wa9tt011sk51q6g
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
8-K
EX-99.1
mea8vtcgfo8m0 u82
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.1
jnrlofma 0k5ayum286o
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
8-K
EX-99.1
jpcyowb t499
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
8-K
EX-99.2
cbzia2ptxqkisrhmu
3 Mar 22
Upsizing and Early Settlement of Tender Offers
4:16pm
8-K
EX-99.1
xbyg0b2 d54u9ni
3 Mar 22
Upsizing and Early Settlement of Tender Offers
4:16pm